NI
CNTX icon

Nextech Invest’s Context Therapeutics CNTX Stock Holding History

Nextech Invest’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4M Hold
7,419,355
– – 1.37% 10
2025
Q4 		$10.9M Hold
7,419,355
– – 1.05% 12
2025
Q3 		$7.19M Hold
7,419,355
– – 1.09% 10
2025
Q2 		$4.86M Hold
7,419,355
– – 0.92% 14
2025
Q1 		$4.54M Hold
7,419,355
– – 1.06% 12
2024
Q4 		$7.79M Hold
7,419,355
– – 1.26% 13
2024
Q3 		$14.5M Hold
7,419,355
– – 2.04% 13
2024
Q2 		$14.9M Buy
+7,419,355
New +$12.8M 2.5% 12

Other funds holding CNTX

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Nextech Invest's CNTX Position: Q1 2026 in Review

Nextech Invest held its Context Therapeutics (CNTX) position steady in Q1 2026 at 7,419,355 shares worth $19.4M. The position accounts for 1.37% of the portfolio, ranked #10.

Nextech Invest first reported a position in CNTX in Q2 2024 and has held it in 8 quarters since. 59 funds tracked by Wall St. Rank hold CNTX as of Q1 2026.

  • Nextech Invest held 7,419,355 shares of Context Therapeutics worth $19.4M as of Q1 2026.
  • Nextech Invest left its Context Therapeutics share count unchanged in Q1 2026.
  • Context Therapeutics made up 1.37% of Nextech Invest's portfolio in Q1 2026, its #10 holding.
  • Nextech Invest first reported a position in Context Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 59 funds tracked by Wall St. Rank held Context Therapeutics as of Q1 2026.

Based on Nextech Invest's 13F filing for Q1 2026, filed 15 May 2026.